You are in:Home/Publications/Serum CCL20: A novel potential marker of cardiovascular risk in alopecia areata patients

Dr. SAMAH EZZAT IBRAHIM SHERIF :: Publications:

Title:
Serum CCL20: A novel potential marker of cardiovascular risk in alopecia areata patients
Authors: Ahmed M. Hameda, Amal M. Abdelmaksouda, Asmaa A. Elfallahb, Enas M. Sweedc, Samah E. Ibrahima
Year: 2023
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: Local
Paper Link: Not Available
Full paper SAMAH EZZAT IBRAHIM SHERIF_serumccl20.pdf
Supplementary materials Not Available
Abstract:

Alopecia areata (AA) is a prevalent autoimmune skin disease that may be associated with systemic disorders. The connection between cardiovascular risks and AA is not widely investigated. Chemokine (C-C motif) ligand 20 (CCL20) has been found to be related to cardiovascular comorbidities. Objective To investigate the role of CCL20 in AA patients and its relation to cardiovascular comorbidity. Patients and methods This study enrolled 80 AA patients and 40 age and sex-matched control subjects. Serums CCL20, high sensitive C- reactive protein (Hs-CRP), lipid profile in addition to carotid intima-media thickness (CIMT) were investigated in all subjects. Results AA patients expressed significantly higher serum CCL20 levels than healthy controls (29.6±20.4 vs. 10.3±6.7, P

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus